Marion de Galembert is an associate in the Corporate - Life Sciences team at DLA Piper. She advises innovative companies in the sector (pharmaceutical companies, medical device manufacturers, CROs/CMOs, biotechs/medtechs) and focuses her practice on transactional and regulatory issues in the healthcare industries.Marion is an associate in the Corporate - Life Sciences team at DLA Piper. She advises innovative companies in the sector (pharmaceutical companies, medical device manufacturers, CROs/CMOs, biotechs/medtechs) and focuses her practice on transactional and regulatory issues in the healthcare industries.
Her practice focuses on transactional and regulatory issues in the healthcare industry. She advises on the negotiation and drafting of strategic contracts (e.g., development, manufacturing, licensing and distribution agreements), as well as on regulatory issues specific to the healthcare sector, such as clinical trials, market access, promotion and advertising, contracts and general compliance issues (transparency and anti-gift / DMOS devices).
